von Tobias Borgers | Apr. 12, 2022 | Continuous Manufacturing
With the increasing number of biologics, complex oncology therapies, and rare and orphan drugs comprising pharma and biopharma pipelines, manufacturing equipment must provide substantial flexibility. Additionally, the COVID-19 pandemic and vaccine production is...
von Tobias Borgers | Apr. 12, 2022 | Continuous Manufacturing
As pharma and biopharma pipelines trend toward biologics, complex oncology therapies, rare and orphan diseases, and with increasingly stringent FDA requirements, the impact on manufacturing equipment necessitates even greater flexibility. Additionally, the COVID-19...
von Tobias Borgers | Apr. 5, 2022 | Allgemein, Tablet Coating
AbstractThree-dimensional (3D) printing is causing a paradigm shift in pharmaceuticals and clinical pharmacy practice, transitioning away from the traditional mass production of medicines towards tailored drug products that are personalised to each individual. The...
von Tobias Borgers | Apr. 5, 2022 | Continuous Manufacturing, Fachzeitschriften, Markt
Tony Margetts explains the industry’s challenges around connecting and collecting THE pharmaceutical industry is ripe for digitalisation, and chemical engineers have a key role to play in helping this conservative sector take advantage of its major benefits. It is a...
von Tobias Borgers | März 22, 2022 | Markt
Samsung Biologics, the biopharmaceutical unit of South Korea’s Samsung Group, is seeking to build its first plants in the US and Europe as it rebalances its global supply chains following the pandemic.The world’s largest contract drugmaker, which produces for other...
